Founded in France in 2001 as a spin-off from INRIA, QuantifiCare – a QIMA Life Sciences company is an international clinical imaging CRO specializing in standardized 2D and 3D photography systems and services for clinical trials. QuantifiCare supports pharmaceutical, biotechnology, medical device and cosmetic companies in documenting treatment efficacy and safety across Phase I–IV multicenter clinical trials.
With more than 25 years of experience in clinical imaging, QuantifiCare combines validated imaging technologies, scientific expertise and responsive project management to deliver consistent, traceable and analysis-ready data. The company operates globally through offices in France, the USA and Japan, supporting clinical trials in more than 80 countries.
QuantifiCare provides clinical imaging services and systems that help sponsors standardize image acquisition, monitor image quality and objectively evaluate changes over time throughout clinical trials.
Services include:
Development of study-specific imaging procedures, site training and operational support
Real-time image monitoring and quality control through a secure web-based portal
Quantitative analysis of skin, surface, volume and morphological changes
Provision, validation and support of portable imaging systems
Imaging solutions for efficacy assessment, safety documentation and product claims
Industries and therapeutic areas served include:
Medical aesthetics
Dermatology
Wound care
Autoimmune diseases
Infectious diseases
Oncology
Rare diseases
QuantifiCare combines standardized clinical image acquisition, real-time data monitoring and objective image analysis to support reliable and reproducible imaging across clinical trials. Its 2D and LifeViz® 3D imaging solutions enable high-quality, standardized image capture across sites, investigators and study visits, supporting longitudinal assessment and comparability of clinical outcomes.
QuantifiCare’s cross-functional teams work closely with sponsors to optimize imaging workflows, improve operational consistency and deliver analysis-ready data throughout the clinical development process. With more than two decades of experience, a global operational footprint and a strong focus on innovation, QuantifiCare brings together scientific expertise, imaging technology, project management and customer support.
QuantifiCare’s quality and compliance framework is designed to support clinical studies in accordance with applicable Good Clinical Practice (GCP), FDA 21 CFR Part 11 and HIPAA requirements. Its quality assurance team maintains Standard Operating Procedures (SOPs) covering key activities from study initiation through database lock and study close-out.
The DermaPix® web portal enables secure image transmission and centralized access to study images, with features supporting automated image quality checks, audit trails, controlled data access, secure data storage and long-term study data archiving for up to 15 years.
As part of QIMA Life Sciences, QuantifiCare strengthens QIMA’s capabilities in clinical imaging, efficacy evaluation and digital data analysis. QuantifiCare’s expertise complements QIMA’s broader network of clinical research, biomarker, analytical and life sciences specialists, providing clients with access to integrated capabilities spanning early product development, clinical research and validation.
Contact our team to learn more about QuantifiCare's clinical imaging CRO services and how they can integrate with QIMA Life Sciences’ global clinical research, testing and analytical capabilities.